These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5065152)

  • 1. Glucagon antibodies after long-term insulin treatment in a diabetic child.
    Stahl M; Nars PW; Herz G; Baumann JB; Girard J
    Horm Metab Res; 1972 May; 4(3):224-5. PubMed ID: 5065152
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the administration of glucagon and insulin antibodies to rats.
    Barling P; Beloff-Chain A
    Horm Metab Res; 1973 May; 5(3):154-9. PubMed ID: 4714540
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagon responses to L-arginine and insulin after treatment of insulin dependent diabetes mellitus in childhood.
    Kodama S; Ninomiya M; Akiyama Y; Takahashi T; Takumi T; Nishio H; Tsubota T; Matsuo T
    Kobe J Med Sci; 1986 Jun; 32(3):77-89. PubMed ID: 3531706
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment.
    Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP
    Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum pancreatic polypeptide and glucagon immunoreactivity in fasting healthy and diabetic children.
    Walczak M; Mrozikiewicz D; Dmochowski K; Rewers M; Cichy W
    Mater Med Pol; 1989; 21(1):38-42. PubMed ID: 2699344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum I-125 insulin IgG binding capacity in diabetic patients on a long-term insulin treatment, with reference to indications for monocomponent insulin therapy].
    Bruni B; Castellazzi R; Osenda M; Papotti G; Turco GL
    Minerva Med; 1974 Mar; 65(20):1071-7. PubMed ID: 4827592
    [No Abstract]   [Full Text] [Related]  

  • 8. [Insulin antibody formation in diabetic children (author's transl)].
    Stögmann W; Statz H
    Padiatr Padol; 1980; 15(4):385-92. PubMed ID: 7007991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin antibodies in juvenile diabetes mellitus. Correlations to diabetic stability, insulin requirement and duration of insulin treatment.
    Keilacker H; Rjasanowski I; Ziegler M; Michaelis D; Woltanski KP; Besch W
    Horm Metab Res; 1982 May; 14(5):227-32. PubMed ID: 7047344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin autoantibodies and insulin-induced antibodies in children with insulin-dependent diabetes].
    Bridel MP; Tubiana-Rufi N; Levy-Marchal C
    Diabete Metab; 1992; 18(6):459-62. PubMed ID: 1297603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin treatment does not induce glucagon antibodies.
    Thomsen HG
    Horm Metab Res; 1971 Jan; 3(1):57-8. PubMed ID: 5128330
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-glucagon antibodies in diabetes mellitus.
    Gergely A; Korányl L; Halmos T; Zsombók M; Péterfy F; Csizér F; Salamon F; Takó J
    Ann Immunol Hung; 1973; 17():231-3. PubMed ID: 4808018
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):455-8. PubMed ID: 8985655
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the radioimmunological determination of blood insulin by means of 125-I-insulin of high specific activity.
    Lawecki J; Rogala H; Kowalski H
    Pol Med J; 1970; 9(6):1338-45. PubMed ID: 5534059
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of naturally acquired type-I and type-II diabetes mellitus in cats.
    Kirk CA; Feldman EC; Nelson RW
    Am J Vet Res; 1993 Mar; 54(3):463-7. PubMed ID: 8498753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin antibodies in diabetic children treated with highly purified porcine NPH insulin. Comparison of results obtained by three methods of insulin antibody determination.
    Mäkelä AL; Akerblom HK; Mäkelä P
    Diabete Metab; 1982 Dec; 8(4):341-8. PubMed ID: 7160521
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum levels of insulin-binding antibodies in diabetic children treated with monocomponent insulin].
    Symonides-Lawecka A; Ludwiczak H; Rogala H; Lawecki J; Czyzyk A
    Pol Tyg Lek; 1974 Apr; 29(16):641-3. PubMed ID: 4827230
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of free and antibody-bound insulin in insulin treated diabetic patients.
    Heding LG
    Horm Metab Res; 1969 May; 1(3):145-6. PubMed ID: 5408729
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of insulin antibodies in insulin treatment of type I diabetes.
    Keilacker H; Rjasanowski I; Ziegler M; Michaelis D; Woltanski KP; Besch W
    Exp Clin Endocrinol; 1986 Jun; 87(1):79-88. PubMed ID: 3527726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Short- and long-term results of intensive insulin therapy in patients with severe forms of diabetes mellitus type I].
    Tikhonova EP; Levchenko TP
    Ter Arkh; 1988; 60(9):17-20. PubMed ID: 3064338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.